- Investing Ideas
- Hong Kong Healthcare Undervalued based on future growth
Hong Kong Healthcare Undervalued based on future growth
Results
7
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
7 companies
Sinopharm Group
Market Cap: HK$51.1b
Engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China.
1099
HK$16.38
7D
-3.6%
1Y
-11.2%
Beijing Chunlizhengda Medical Instruments
Market Cap: HK$5.9b
Engages in the research, development, production, and sale of surgical implants, instruments, and related products in the People’s Republic of China and internationally.
1858
HK$8.81
7D
-4.6%
1Y
-18.4%
Hygeia Healthcare Holdings
Market Cap: HK$5.4b
Offers oncology healthcare services in the People's Republic of China.
6078
HK$8.78
7D
-3.3%
1Y
-39.5%
LEPU ScienTech Medical Technology (Shanghai)
Market Cap: HK$3.0b
An investment holding company, engages in the manufacture and sale of interventional treatment series occluders and heart valve medical devices.
2291
HK$8.73
7D
-7.2%
1Y
-57.4%
Chaoju Eye Care Holdings
Market Cap: HK$1.7b
Owns and operates a network of ophthalmic hospitals and centers in the People’s Republic of China.
2219
HK$2.50
7D
-1.6%
1Y
-4.9%
Sisram Medical
Market Cap: HK$1.1b
Engages in the research, design, development, manufacture, sale, and marketing of medical aesthetics and dental equipment, home-use devices, injectables, and cosmeceutical products in the Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America.
1696
HK$2.38
7D
-5.6%
1Y
-47.7%
Yonghe Medical Group
Market Cap: HK$1.0b
Provides hair-related healthcare services in China.
2279
HK$2.07
7D
0.5%
1Y
76.9%